Stocks›Healthcare›ALNY

ALNY

ALNYLAM PHARMACEUTICALS, INC.

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$32.1B

Enterprise Value$31.1B

Income$313.7M

Sales$3.7B

Book/sh$5.90

Cash/sh$12.40

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio2.71

Current Ratio2.76

Debt/Eq0.86

EPS (ttm)$2.33

EPS this Y206.9%

EPS past 3/5Y—

Sales past 3/5Y53.0%

EPS Y/Y TTM206.9%

Sales Y/Y TTM65.2%

Shs Outstand133.81M

ROA6.3%

ROE39.8%

ROIC—

Gross Margin—

Oper. Margin13.5%

Profit Margin8.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$844.3M

2021

$1.0B

2022

$1.8B

2023

$2.2B

2024

$3.7B

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$844.3M	$1.0B	$1.8B	$2.2B	$3.7B
Gross Profit	—	—	—	—	—
Operating Income	$-708.7M	$-785.1M	$-282.2M	$-176.9M	$501.6M
Net Income	$-852.8M	$-1.1B	$-440.2M	$-278.2M	$313.7M
Diluted EPS	$-7.20	$-9.30	$-3.52	$-2.18	$2.33
Operating Cash Flow	$-641.7M	$-541.3M	$104.2M	$-8.3M	$524.1M
Free Cash Flow	$-718.1M	$-613.3M	$41.9M	$-42.6M	$465.4M